Resultados de la búsqueda 21-30 de 26441 para Relapse
... relapse (Phase I), and to determine the antitumor effectiveness of the combination of NMS-03305293 and TMZ in patients with isocitrate dehydrogenase (IDH) ...
... Relapsed/Refractory Multiple Myeloma (RRMM). Sapanisertib in Treating ... Patients at high risk of relapse are eligible for InPACT-pelvis, where they ...
... relapsed acute leukemia (AML or ALL) for future biological studies. By accruing samples both at initial diagnosis and at relapse, we will be able to ...
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer ... relapsed/refractory solid tumor ...
... relapse will improve disease-free survival (DFS). Risk stratification will ... relapsed and frontline CD123-positive AML, and antileukemia activity of ...
... Relapsed FHWT. Rochester, Minn. The purpose of this study is to evaluate how ... (relapsed). Drugs used in chemotherapy regimens such as UH-3 (vincristine ...
The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...
Rochester, Minn. The purpose of this study is to determine the safety and preliminary efficacy of voruciclib as monotherapy in subjects with relapsed or ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?